Literature DB >> 26607577

Comparison of MR imaging findings in paediatric and adult patients with acute mastoiditis and incidental intramastoid bright signal on T2-weighted images.

R Saat1,2, G Mahmood3, A Laulajainen-Hongisto4, L Lempinen4, A A Aarnisalo4, J Jero4, A Markkola3.   

Abstract

OBJECTIVES: To compare MR imaging features in patients with incidental mastoid T2-hyperintensity with those of clinical acute mastoiditis, to ascertain characteristic differences between them.
METHODS: MR images of 35 adult and paediatric patients with clinical acute mastoiditis and 34 consecutive age-matched controls without relevant middle ear pathology and with incidental T2-hyperintensity that covered ≥ 50 % of the mastoid were retrospectively analysed with regard to signal, diffusion, and enhancement characteristics, and presence of complications.
RESULTS: Incidental mastoid T2-hyperintensity that covered ≥ 50 % of the mastoid volume was found in 4.6 % of reviewed MR scans (n = 2341), and associated significantly (p < 0.05) less with the involvement of the tympanic cavity (38 % vs. 74 %) and mastoid antrum (56 % vs. 80 %), hypointense-to-CSF signal intensity on T2 FSE (6 % vs. 86 %), intramastoid diffusion restriction (0 % vs. 62 %), intense intramastoid enhancement (0 % vs. 51 %), periosteal enhancement (3 % vs. 69 %), perimastoid dural enhancement 3 % vs. 43 %), bone destruction (0 % vs 49 %), intratemporal abscess or cholesteatoma (0 % vs. 24 %), labyrinth involvement (0 % vs. 14 %), and extracranial abscesses (0 % vs. 20 %).
CONCLUSION: Hypointense-to-CSF signal intensity on T2WI, restricted diffusion, intense intramastoid enhancement among other MR imaging characteristics favoured an acute mastoiditis diagnosis over clinically non-relevant incidental mastoid pathology. KEY POINTS: • Intramastoid T2-hyperintensity alone is not a reliable sign for acute mastoiditis. • In acute mastoiditis, intramastoid T2-weighted signal intensity is usually hypointense to CSF. • Diffusion restriction and intense intramastoid enhancement are absent in incidental mastoid effusion. • An ADC value ≥ 1.72 × 10 (-3) mm (2) /s contradicts the AM diagnosis.

Entities:  

Keywords:  Magnetic resonance imaging; Mastoiditis; Middle ear; Otitis media; Temporal bone

Mesh:

Year:  2015        PMID: 26607577     DOI: 10.1007/s00330-015-4113-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Algorithmic management of pediatric acute mastoiditis.

Authors:  Ioannis M Psarommatis; Charalampos Voudouris; Konstantinos Douros; Polyvios Giannakopoulos; Theodoros Bairamis; Charalampos Carabinos
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-03-09       Impact factor: 1.675

2.  Incidental diagnosis of mastoiditis on MRI.

Authors:  Senol Polat; Elif Aksoy; Gediz Murat Serin; Erdem Yıldız; Hasan Tanyeri
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-05       Impact factor: 2.503

3.  Acute otitis media and mastoid growth.

Authors:  Jacob Sadé; Eyal Russo; Camil Fuchs; Amos Ar
Journal:  Acta Otolaryngol       Date:  2006-10       Impact factor: 1.494

4.  MR imaging features of acute mastoiditis and their clinical relevance.

Authors:  R Saat; A H Laulajainen-Hongisto; G Mahmood; L J Lempinen; A A Aarnisalo; A T Markkola; J P Jero
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-16       Impact factor: 3.825

Review 5.  Otitis media with effusion: an effort to understand and clarify the uncertainties.

Authors:  Fotini-Maria Chantzi; Theodoros Bairamis; Nikolaos G Papadopoulos; Dimitris A Kafetzis
Journal:  Expert Rev Anti Infect Ther       Date:  2005-02       Impact factor: 5.091

6.  Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging.

Authors:  Ping H Lai; Jih T Ho; Wei L Chen; Shu S Hsu; Jyh S Wang; Huay B Pan; Chien F Yang
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

7.  The prevalence and significance of incidental middle ear and mastoid cavity abnormalities on MRI in a pediatric population.

Authors:  Ali Balci; Ozlem Sangun; Semsettin Okuyucu; Sinem Karazincir; Ertap Akoglu; Yasemin Altintas; Ertugrul Egilmez
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-11-04       Impact factor: 1.675

8.  Clinical significance of incidental magnetic resonance image abnormalities in mastoid cavity and middle ear in children.

Authors:  Karin Blomgren; Soraya Robinson; Tuula Lönnqvist; Harri Saxèn; Anne Pitkäranta
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-07       Impact factor: 1.675

Review 9.  Complications of acute otitis media in children.

Authors:  Kimmo Leskinen
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

10.  Magnetic resonance imaging in acute mastoiditis.

Authors:  Ivan Platzek; Hagen H Kitzler; Volker Gudziol; Michael Laniado; Gabriele Hahn
Journal:  Acta Radiol Short Rep       Date:  2014-02-25
View more
  4 in total

Review 1.  Role of Diffusion Weighted Imaging in Musculoskeletal Infections: Current Perspectives.

Authors:  Yogesh Kumar; Mohammad Khaleel; Ethan Boothe; Haitham Awdeh; Vibhor Wadhwa; Avneesh Chhabra
Journal:  Eur Radiol       Date:  2016-05-10       Impact factor: 5.315

Review 2.  Differentiating Acute Otitis Media and Acute Mastoiditis in Hospitalized Children.

Authors:  Anu Laulajainen-Hongisto; Antti A Aarnisalo; Jussi Jero
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

3.  Spaceflight-Associated Changes in the Opacification of the Paranasal Sinuses and Mastoid Air Cells in Astronauts.

Authors:  Dani C Inglesby; Michael U Antonucci; Maria Vittoria Spampinato; Heather R Collins; Ted A Meyer; Rodney J Schlosser; Kazuhito Shimada; Donna R Roberts
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-06-01       Impact factor: 6.223

4.  Detection of Coalescent Acute Mastoiditis on MRI in Comparison with CT.

Authors:  R Saat; G Kurdo; A Laulajainen-Hongisto; A Markkola; J Jero
Journal:  Clin Neuroradiol       Date:  2020-07-21       Impact factor: 3.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.